Related Experiment Video
Updated: Jun 23, 2026

09:27
New Tools to Expand Regulatory T Cells from HIV-1-infected Individuals
Published on: May 30, 2013
Probing the possibilities for T-cell-based AIDS vaccines
David A Garber1, Mark B Feinberg
1Emory Vaccine Center, Atlanta, Georgia, USA.
Current Opinion in HIV and AIDS
|April 18, 2009
Summary
Developing an effective AIDS vaccine remains challenging. Current research focuses on cellular immune responses and understanding HIV infection to overcome hurdles in vaccine design and achieve a successful vaccine.
Area of Science:
- Immunology
- Virology
- Vaccinology
Background:
- Recent advances in understanding HIV transmission, CD4 T-cell dynamics, and CD8 T-cell responses offer new insights into infection.
- These insights highlight key scientific challenges in creating a safe and effective AIDS vaccine.
Purpose of the Study:
- To review current challenges in AIDS vaccine development.
- To discuss approaches aimed at overcoming these challenges.
- To emphasize vaccines targeting cellular immune responses over humoral responses.
Main Methods:
- Review of current scientific literature on AIDS vaccine development.
- Analysis of recent findings in HIV biology and immunology.
- Evaluation of experimental vaccine design, administration, and assessment strategies.
Main Results:
- Improved understanding of HIV infection biology, including mucosal transmission and T-cell dynamics.
- Identification of critical scientific hurdles for AIDS vaccine development.
- Diverse experimental approaches are being pursued to address these hurdles.
Conclusions:
- An effective AIDS vaccine is yet to be developed.
- Enhanced knowledge of HIV pathogenesis and immunity is guiding new hypotheses.
- Further research is needed to overcome obstacles and advance AIDS vaccine realization.
More Related Videos
Related Concept Videos
T Cell Activation and Clonal Selection
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cell-mediated Immune Responses
Overview

